BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 23535213)

  • 1. Programmable plasmid interference by the CRISPR-Cas system in Thermococcus kodakarensis.
    Elmore JR; Yokooji Y; Sato T; Olson S; Glover CV; Graveley BR; Atomi H; Terns RM; Terns MP
    RNA Biol; 2013 May; 10(5):828-40. PubMed ID: 23535213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An active immune defense with a minimal CRISPR (clustered regularly interspaced short palindromic repeats) RNA and without the Cas6 protein.
    Maier LK; Stachler AE; Saunders SJ; Backofen R; Marchfelder A
    J Biol Chem; 2015 Feb; 290(7):4192-201. PubMed ID: 25512373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential requirements for the detection and degradation of invaders by the Haloferax volcanii CRISPR/Cas system I-B.
    Maier LK; Lange SJ; Stoll B; Haas KA; Fischer S; Fischer E; Duchardt-Ferner E; Wöhnert J; Backofen R; Marchfelder A
    RNA Biol; 2013 May; 10(5):865-74. PubMed ID: 23594992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three CRISPR-Cas immune effector complexes coexist in Pyrococcus furiosus.
    Majumdar S; Zhao P; Pfister NT; Compton M; Olson S; Glover CV; Wells L; Graveley BR; Terns RM; Terns MP
    RNA; 2015 Jun; 21(6):1147-58. PubMed ID: 25904135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA targeting by the type I-G and type I-A CRISPR-Cas systems of Pyrococcus furiosus.
    Elmore J; Deighan T; Westpheling J; Terns RM; Terns MP
    Nucleic Acids Res; 2015 Dec; 43(21):10353-63. PubMed ID: 26519471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate generation for endonucleases of CRISPR/cas systems.
    Zoephel J; Dwarakanath S; Richter H; Plagens A; Randau L
    J Vis Exp; 2012 Sep; (67):. PubMed ID: 22986408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic determinants of PAM-dependent DNA targeting and pre-crRNA processing in Sulfolobus islandicus.
    Peng W; Li H; Hallstrøm S; Peng N; Liang YX; She Q
    RNA Biol; 2013 May; 10(5):738-48. PubMed ID: 23392249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RNA- and DNA-targeting CRISPR-Cas immune systems of Pyrococcus furiosus.
    Terns RM; Terns MP
    Biochem Soc Trans; 2013 Dec; 41(6):1416-21. PubMed ID: 24256230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A complex of Cas proteins 5, 6, and 7 is required for the biogenesis and stability of clustered regularly interspaced short palindromic repeats (crispr)-derived rnas (crrnas) in Haloferax volcanii.
    Brendel J; Stoll B; Lange SJ; Sharma K; Lenz C; Stachler AE; Maier LK; Richter H; Nickel L; Schmitz RA; Randau L; Allers T; Urlaub H; Backofen R; Marchfelder A
    J Biol Chem; 2014 Mar; 289(10):7164-7177. PubMed ID: 24459147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-cleavage activity of Cas6b in crRNA processing of two different CRISPR-Cas systems in Methanosarcina mazei Gö1.
    Nickel L; Ulbricht A; Alkhnbashi OS; Förstner KU; Cassidy L; Weidenbach K; Backofen R; Schmitz RA
    RNA Biol; 2019 Apr; 16(4):492-503. PubMed ID: 30153081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of an RNA silencing complex of the CRISPR-Cas immune system.
    Spilman M; Cocozaki A; Hale C; Shao Y; Ramia N; Terns R; Terns M; Li H; Stagg S
    Mol Cell; 2013 Oct; 52(1):146-52. PubMed ID: 24119404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining the Specificity of Cascade Binding, Interference, and Primed Adaptation
    Cooper LA; Stringer AM; Wade JT
    mBio; 2018 Apr; 9(2):. PubMed ID: 29666291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ring of confidence: a haloarchaeal CRISPR/Cas system.
    Maier LK; Stoll B; Brendel J; Fischer S; Pfeiffer F; Dyall-Smith M; Marchfelder A
    Biochem Soc Trans; 2013 Feb; 41(1):374-8. PubMed ID: 23356314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approaches to study CRISPR RNA biogenesis and the key players involved.
    Behler J; Hess WR
    Methods; 2020 Feb; 172():12-26. PubMed ID: 31325492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the CRISPR-Cas RNA silencing Cmr complex bound to a target analog.
    Osawa T; Inanaga H; Sato C; Numata T
    Mol Cell; 2015 May; 58(3):418-30. PubMed ID: 25921071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Repression in Haloarchaea Using the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)-Cas I-B System.
    Stachler AE; Marchfelder A
    J Biol Chem; 2016 Jul; 291(29):15226-42. PubMed ID: 27226589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirements for a successful defence reaction by the CRISPR-Cas subtype I-B system.
    Stoll B; Maier LK; Lange SJ; Brendel J; Fischer S; Backofen R; Marchfelder A
    Biochem Soc Trans; 2013 Dec; 41(6):1444-8. PubMed ID: 24256235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential features and rational design of CRISPR RNAs that function with the Cas RAMP module complex to cleave RNAs.
    Hale CR; Majumdar S; Elmore J; Pfister N; Compton M; Olson S; Resch AM; Glover CV; Graveley BR; Terns RM; Terns MP
    Mol Cell; 2012 Feb; 45(3):292-302. PubMed ID: 22227116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An archaeal CRISPR type III-B system exhibiting distinctive RNA targeting features and mediating dual RNA and DNA interference.
    Peng W; Feng M; Feng X; Liang YX; She Q
    Nucleic Acids Res; 2015 Jan; 43(1):406-17. PubMed ID: 25505143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmable type III-A CRISPR-Cas DNA targeting modules.
    Ichikawa HT; Cooper JC; Lo L; Potter J; Terns RM; Terns MP
    PLoS One; 2017; 12(4):e0176221. PubMed ID: 28441427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.